Gut Microbes Differ in Men with Prostate Cancer
European Association of UrologyResearchers have found a significant difference in the gut microbiota of men with prostate cancer, compared with those who have benign biopsies.
Researchers have found a significant difference in the gut microbiota of men with prostate cancer, compared with those who have benign biopsies.
Researchers in Center of Excellence for Evolutionary Therapy at Moffitt Cancer Center are thinking outside the box and studying an alternative approach called adaptive therapy that is based on evolutionary principles and mathematical modeling. In a new article in eLife, the researchers report updated results from a pilot clinical trial evaluating an adaptive therapy approach using the drug abiraterone to treat patients with metastatic castrate-resistant prostate cancer.
Military sexual trauma (MST) can have a corrosive impact on trust within the U.S. military, as well as a number of negative effects on the individual. A recent study has examined the prevalence of MST history among U.S. Army Reserve/National Guard (USAR/NG) soldiers, the extent to which MST history predicts risk for alcohol misuse and problems, and potential sex differences in these experiences and outcomes. Findings indicate that MST is alarmingly prevalent for both female and male service members; in fact, the prevalence of MST appears to be much higher for male service members than is often reported.
Dr. Michael Stifelman, chair of Urology at Hackensack Meridian Health, shares the latest and greatest in prostate cancer screenings and treatments.
Many male couples in the U.S. seem to be underestimating the effectiveness of HIV pre-exposure prophylaxis (PrEP) for HIV prevention, and educating partners together could improve the number of male couples who decide to adopt PrEP. These conclusions come from a study reported in the July/August issue of The Journal of the Association of Nurses in AIDS Care (JANAC), the official journal of the Association of Nurses in AIDS Care. JANAC is published in the Lippincott portfolio by Wolters Kluwer.
In a new article published in Science Translational Medicine, Moffitt Cancer Center researchers reveal a mechanism by which prostate cancer cells become resistant through molecular modification of the androgen receptor protein and identify a potential treatment approach that could overcome this resistance.
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include preclinical discoveries for combination therapies to treat breast, ovarian and colorectal cancers; a new treatment target for rare sarcomas; a novel CRISPR engineering approach to facilitate in vivo research; and multiple studies of signal pathways that enhance anti-tumor immune responses.
In a pilot study, researchers in ACS’ Journal of Agricultural and Food Chemistry report that compared to their pre-trial microbiome, men who drank either one alcoholic or non-alcoholic lager daily had a more diverse set of gut microbes, which can reduce the risk for some diseases.
Here are some of the latest articles that have been added to the Aging channel on Newswise, a free source for journalists.
A new survey from the American Academy of Sleep Medicine (AASM) reveals that 75% of men have stayed up “past their bedtime” and lost sleep due to video games, and 62% have lost sleep due to alcohol.
Active testosterone therapy for transgender men may negatively impact IVF outcomes, suggests a mouse study being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
New research suggests that more careful control of body weight in childhood and adolescence could help prevent male infertility later in life. The researchers will present their findings on Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Two experimental male contraceptive pills appear to effectively lower testosterone without causing unacceptable side effects, according to a new study that will be presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Testosterone replacement therapy improved sexual symptoms, libido, symptom severity, delayed verbal recall and overall quality of life among people with poorly controlled type 2 diabetes and hypogonadism, according to research being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new study co-led by a Cedars-Sinai Cancer investigator.
Christopher M. Gonzalez, MD, MBA, FACS, chair of the urology department at Loyola University Medical Center, has been awarded the Barringer Medal from the American Association of Genitourinary Surgeons. Dr. Gonzalez was also recently elected Trustee to the American Board of Urology (ABU). His six-year term began on April 2, 2022.
Previous clinical trials have provided insufficient evidence to decide whether testosterone causes heart problems in men during the first year of treatment, according to research being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga., and published in The Lancet Healthy Longevity.
Investigators from the Women’s Guild Lung Institute at Cedars-Sinai have discovered that zinc, a common mineral, may reverse lung damage and improve survival for patients with a deadly age-related condition known as idiopathic pulmonary fibrosis (IPF).